Multiplicom
#Multiplicom is the leading Belgian biotech company that develops, manufactures and commercializes molecular diagnostic tests that enable personalized medicine.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 33 % | (20 %) | (4 %) | (29 %) | 37 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (8 %) | (2 %) | (65 %) | (56 %) | (72 %) | (84 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (20 %) | (14 %) | (73 %) | (65 %) | (82 %) | (91 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Multiplicom is a pioneering company in the life sciences sector, specializing in the development and production of advanced scientific instruments and software solutions. The company primarily serves laboratories, research institutions, and clinical diagnostics labs. Multiplicom operates in the global market, providing cutting-edge tools and technologies that enhance the efficiency and accuracy of scientific research and diagnostics.
The business model of Multiplicom revolves around the sale of high-performance instruments, such as their LC MS (Liquid Chromatography-Mass Spectrometry) systems, and integrated software solutions like LIMS (Laboratory Information Management Systems) and ELN (Electronic Laboratory Notebooks). These products help labs manage their workflows, data, and processes more effectively. Additionally, Multiplicom offers training and educational resources, including virtual instructor-led training and webinars, to ensure that their clients can maximize the use of their products.
Multiplicom generates revenue through the direct sale of its instruments and software, as well as through ongoing service contracts and training programs. By providing comprehensive solutions that cover the entire workflow of glycan analysis and other scientific processes, the company ensures a steady stream of income from both new and existing clients.
In summary, Multiplicom is a key player in the life sciences industry, offering innovative instruments and software solutions that help laboratories and research institutions achieve superior outcomes. Their business model focuses on product sales, service contracts, and educational resources, ensuring a robust and diversified revenue stream.
Keywords: Life Sciences, Instrumentation, Software Solutions, Laboratories, Research, Clinical Diagnostics, Workflow Management, Training, Glycan Analysis, Innovation.